Quantcast

Latest Lower urinary tract symptoms Stories

2009-08-17 01:00:00

QUEBEC CITY, Aug. 17 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna...

2009-08-03 07:00:00

WALTHAM, Mass., Aug. 3 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, from 2013 to 2018, generic erosion of established agents--most notably tamsulosin--will cause a decline of more than eight percent in the drug market for benign prostatic hyperplasia and male lower urinary tract symptoms in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Generic erosion will...

2009-06-23 12:08:02

People with mild to severe urinary tract symptoms are more likely to suffer metabolic syndrome, U.S. and British researchers said. The researchers at the New England Research Institutes in Watertown, Mass.; Northwestern University in Chicago; Cornell University, Weill Medical College in New York, Pfizer Inc., in New York; and Pfizer Ltd. in Sandwich, England; explored the association between urinary track symptoms and metabolic syndrome using data from the Boston Area Community Health...

2009-06-19 09:40:51

According to new study published in the Journal of Urology Researchers have determined that individuals with mild to severe symptoms of lower urinary tract symptoms (LUTS) are more likely to suffer from metabolic syndrome (MetS), a collection of cardiovascular risk factors thought to be linked by insulin resistance). LUTS encompass voiding (incomplete emptying, weak stream, intermittency, straining) and storage (frequency, urgency, nocturia) difficulties. In a study published in the August...

2009-06-10 06:15:00

QUEBEC CITY, June 10 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the opening of an extended study in the Phase 3 program with cetrorelix pamoate for the treatment of benign prostatic hyperplasia (BPH), a benign enlargement of the prostate, affecting more than 20 million men in the U.S. alone. Sanofi-aventis U.S. LLC entered into a previously announced agreement with...

2009-04-27 17:13:16

Some college-age U.S. women may be at higher risk of developing urinary tract infections, researchers said. University of Florida researchers found two behaviors -- increased sexual activity and increased alcohol consumption -- linked to an increase in women's UTI. The researchers say college-age women experiencing urinary frequency or urgency should seek medical care to treat what may be their first UTI. The researchers surveyed 181 women with their first UTI who came to the student...

2009-04-27 09:46:00

LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Several new studies presented at the American Urological Association's (AUA) 104th Annual Scientific Meeting suggest that the use of statins--commonly prescribed to lower cholesterol--may benefit men with prostate cancer, erectile dysfunction or lower urinary tract symptoms (LUTS). Several key research studies highlighting these benefits will be presented during a special panel for the media on Monday, April 27 from 9 to 10:30 a.m. during...

2009-04-27 09:39:00

LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Men taking generic drugs may be more likely to have less effective results and more adverse events than if they were using branded medications, according to new data from researchers in New York. Researchers presented a study at the 104th Annual Scientific Meeting of the American Urological Association (AUA) showing that generic substitutes for alpha blockers and 5-alpha reductase inhibitors (5-ARIs), two classes of medications used to treat...

2009-04-27 09:28:00

LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonio and Indianapolis will present these findings during the 104th Annual Scientific Meeting of the American Urological Association (AUA). In this study, researchers randomly separated 200 men, with an age equal to or older than 40 years and at least a six month diagnosis of BPH-LUTS with an...

2009-03-06 06:00:00

All amounts are in US dollars QUEBEC CITY, March 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the signing of a development, commercialization and licensing agreement with sanofi-aventis (EURONEXT: SAN; NYSE: SNY) for the development, registration and marketing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market. Cetrorelix, a luteinizing...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.